This improvement is directly associated with the reduction in body fat especially visceral fat since the visceral fat by means of proinflammation and oxidative stress conditions plays an important role in the appearance of obesity comorbidities as diabetes type II, resistance insulin, metabolic syndrome, dyslipidemia, etc. [33]. The gene discussed is INS; the disease is obesity disorder.